Bosutinib Sandoz
Bosutinib Sandoz is a generic from Sandoz Pharmaceuticals AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 380.70 to CHF 1'733.50 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Sandoz Pharmaceuticals AG
- ATC code
- L01EA04
- IT group
- 07.16.10 Cytostatica
- Active substances
- Bosutinibum
- Preparation type
- Generic
- On the SL since
- 01/04/2025
- Last price change
- 01/04/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 100 mg | Blist 28 Stk | CHF 334.95 | CHF 380.70 | 01/04/2025 | A | 7680691450013 |
| Filmtabl 400 mg | Blist 28 Stk | CHF 1'339.80 | CHF 1'473.55 | 01/04/2025 | A | 7680691450020 |
| Filmtabl 500 mg | Blist 28 Stk | CHF 1'578.83 | CHF 1'733.50 | 01/04/2025 | A | 7680691450037 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Bosutinib Sandoz ist indiziert für die Behandlung von erwachsenen Patienten mit Philadelphia-Chromosom positiver chronisch myeloischer Leukämie (Ph+ CML) in der chronischen Phase, in der akzelerierten Phase sowie in der Blastenkrise, nach Vorbehandlung mit einem oder mehreren c-abl Tyrosinkinase Inhibitoren und wenn eine Behandlung mit Imatinib, Nilotinib oder Dasatinib nicht in Frage kommt.
More preparations in this group
FAQ
Is Bosutinib Sandoz covered by Swiss health insurance?
Yes, but only under conditions. Bosutinib Sandoz is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Bosutinib Sandoz cost in Switzerland?
The public price is the maximum price set by the FOPH and for Bosutinib Sandoz ranges from CHF 380.70 to CHF 1'733.50 per pack. The ex-factory price ranges from CHF 334.95 to CHF 1'578.83. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages